HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
THURSDAY, Sept. 24, 2015 (HealthDay News) -- Greater numbers of high-risk women eligible for primary prevention of breast cancer are identified by incorporating benign breast disease (BBD) diagnoses into the Breast Cancer Surveillance Consortium (BCSC) risk model, according to a study published online Aug. 17 in the Journal of Clinical Oncology.
Jeffrey A. Tice, M.D., from the University of California, San Francisco, and colleagues developed and validated a competing-risk model using 2000 to 2010 Surveillance, Epidemiology, and End Results data for breast cancer incidence and 2010 vital statistics to adjust for the competing risk of death.
The researchers found that of the 1,135,977 women (age 35 to 74 years) undergoing mammography with no history of breast cancer, 17 percent had a prior breast biopsy. Invasive breast cancer was diagnosed in 17,908 women over a mean follow-up of 6.9 years. Risk was slightly over-predicted using the BCSC BBD model (expected-to-observed ratio, 1.04) and had modest discriminatory accuracy (area under the receiver operator characteristic curve, 0.665). Adding BBD to the model increased the proportion of women with proliferative findings, with an estimated five-year risk of 3 percent or higher increasing from 9.3 to 27.8 percent (P < 0.001).
"Greater numbers of high-risk women eligible for primary prevention after BBD diagnosis are identified using the BCSC BBD model," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022